To compare the effect of Tramadol versus Nalbuphine as adjuvants to Ropivacaine in transversus abdominis plane block for post-operative analgesia.

A prospective, randomized study to compare the efficacy of Tramadol versus Nalbuphine as adjuvants to Ropivacaine in transversus abdominis plane block for post-operative analgesia in patients undergoing elective abdominal hysterectomy under spinal anesthesia. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099175

Enrollment

Registered

2025-12-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Inj tramadol + inj ropivacaine: Inj. Ropivacaine (0.2%) 40ml + Inj. Tramadol 1mg/kg, total drug will be diluted upto 50ml using normal saline and 25ml drug is given on each side bilater

Eligibility

Inclusion criteria

Inclusion criteria: Patient giving consent Patient with asa grade 1,2 Patient posted for elective abdominal hysterectomy surgery under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Patient not giving consent Patient with asa grade 3,4,5 Patient who is having comorbidities like diabetes and hypertension

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of tramadol vs nalbuphine as an adjuvant to ropivacaine in transverse abdominis plane blockTimepoint: 0 to 24 hours	—

Secondary

Measure	Time frame
Time at which rescue analgesia is given and post operative hemodynamic responseTimepoint: 0 to 24 hours	—

Countries

India

Contacts

Public ContactDr Jatin Patel

Smt. Bhikiben Kanjibhai Shah Medical Institute and Research Centre

dr_jatinpatel@yahoo.co.in9879368363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026